Safety Value TEECAD attaches to the transesophageal echocardiography probe to visualize the upper airway during placement, reducing the risk of failed intubation and esophageal injury. This safety-centric value proposition speaks to hospital and cardiology/anesthesia departments aiming to improve patient outcomes and procedural quality.

Buyers & Partners Key buyers are hospitals, cardiology labs, and anesthesia departments; influencers include clinicians and risk managers. Channel growth can be driven through medical device distributors and group purchasing organizations, with ASE conferences as a key lead generation and relationship-building venue.

Evidence-Based Selling Clinical data from the TEECAD product registry being presented at major conferences provides evidence to support adoption and reimbursement conversations. Early pilots with select centers can generate outcomes data to accelerate uptake.

Growth Momentum Recent financing activity and ongoing product expansion signal momentum and the ability to scale commercialization. Partnerships with distributors and hospital networks can broaden access to TEECAD and accelerate adoption.

Product Roadmap The TEECAD mini expands compatibility to smaller TEE probes, creating cross-sell opportunities within existing user bases. Roadmap opportunities include deeper integration with imaging workflows, training offerings, and bundled service options.